Cargando…
LB1581. Exhalation Delivery System with Fluticasone (EDS-FLU) Significantly Reduces Acute Exacerbations and Associated Antibiotic Use in Chronic Rhinosinusitis
BACKGROUND: Data suggest chronic rhinosinusitis (CRS) may be the top reason for adult outpatient antibiotic use; of ≈10 million office visits per year for CRS, ≈70% result in antibiotic use. Acute exacerbations of CRS (AECRS) are common, possibly due to persistently impaired mucociliary clearance, a...
Autor principal: | Mahmoud, Ramy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752614/ http://dx.doi.org/10.1093/ofid/ofac492.1891 |
Ejemplares similares
-
EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis
por: Palmer, James N., et al.
Publicado: (2018) -
Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgery
por: Ow, Randall A., et al.
Publicado: (2022) -
NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the
Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With
Nasal Polyps
por: Sindwani, Raj, et al.
Publicado: (2018) -
1581O Estimation of European cancer burden for the year 2020
por: Dyba, T.A., et al.
Publicado: (2020) -
Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers
por: Roca-Ferrer, Jordi, et al.
Publicado: (2018)